Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
The review found no eligible studies for this question.
Standard interferon showed no clear difference in treatment discontinuation compared with placebo or control (moderate certainty).
Standard interferon showed no clear difference in adverse events compared with placebo or control (moderate certainty).
Cerebrolysin or Cerebrolysin‐like agents showed no clear difference in all‐cause death ( compared with placebo (moderate certainty).
It is very uncertain whether cerebrolysin or Cerebrolysin‐like agents changes non‐death attrition compared with placebo (very low certainty).
Cerebrolysin or Cerebrolysin‐like agents showed no clear difference in total number of people with SAEs** compared with placebo (moderate certainty).
Cerebrolysin or Cerebrolysin‐like agents showed no clear difference in total number of people with adverse events, compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Angiotensin‐converting enzyme inhibitors showed no clear difference in death (any cause) compared with placebo (low certainty).
Angiotensin‐converting enzyme inhibitors showed no clear difference in CVD events: total (fatal and non‐fatal) compared with placebo (low certainty).
Angiotensin‐converting enzyme inhibitors may leads to higher adverse events: number reporting an adverse event compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether angiotensin receptor blockers changes adverse events (number reporting an adverse event) compared with placebo (very low certainty).
Statin therapy leads to lower major cardiovascular events (MACE) compared with placebo or standard of care (high certainty).
Statin therapy leads to lower death compared with placebo or standard of care (high certainty).